Loading...

Medicus Pharma Ltd.

MDCXWNASDAQ
Healthcare
Biotechnology
$0.88
$-0.02(-2.22%)

Medicus Pharma Ltd. (MDCXW) Stock Overview

Explore Medicus Pharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap45.1M
P/E Ratio-0.76
EPS (TTM)N/A
ROE-3.79%

AI Price Forecasts

1 Week$1.19
1 Month$3.31
3 Months$0.00
1 Year Target$1.29

MDCXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Medicus Pharma Ltd. (MDCXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.76 and a market capitalization of 45.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for MDCXWStats details for MDCXW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MDCXWAnalyst Recommendations details for MDCXW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets. Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.

CEO

Raza Bokhari MBA

Employees

12

Headquarters

One First Canadian Place, Suite 3400 Toronto, ON M5X 1A, Toronto

Founded

2024

Frequently Asked Questions

;